Eplerenone

BNF:
2.2.3
Status:
Grey
Decision Date:
None
 

Comments

Second line mineralocorticoid receptor antagonist for Heart Failure with reduced ejection fraction, if spironolactone is not suitable. (Usually young men <50 years due to risk of gynaecomastia) (Decision date  - Feb 2019)

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app